CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.

Chen S, Yang C, Wang ZW, Hu JF, Pan JJ, Liao CY, Zhang JQ, Chen JZ, Huang Y, Huang L, Zhan Q, Tian YF, Shen BY, Wang YD

DOI: 10.1186/s13045-021-01072-8
Published: 2021 Apr 13
Container: Journal of hematology & oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13045-021-01072-8,
  title = {CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.},
  author = {Chen S and Yang C and Wang ZW and Hu JF and Pan JJ and Liao CY and Zhang JQ and Chen JZ and Huang Y and Huang L and Zhan Q and Tian YF and Shen BY and Wang YD},
  year = {2021},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-021-01072-8},
  url = {https://doi.org/10.1186/s13045-021-01072-8}
}

RIS

TY  - JOUR
TI  - CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
AU  - Chen S
AU  - Yang C
AU  - Wang ZW
AU  - Hu JF
AU  - Pan JJ
AU  - Liao CY
AU  - Zhang JQ
AU  - Chen JZ
AU  - Huang Y
AU  - Huang L
AU  - Zhan Q
AU  - Tian YF
AU  - Shen BY
AU  - Wang YD
PY  - 2021
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-021-01072-8
UR  - https://doi.org/10.1186/s13045-021-01072-8
ER  -

APA

S, C., C, Y., ZW, W., JF, H., JJ, P., CY, L., JQ, Z., JZ, C., Y, H., L, H., Q, Z., YF, T., BY, S., & YD, W. (2021). CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-021-01072-8

Source records

pubmed · retrieved 2026-09-26T00:34:11.758Z